| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Repligen Corporation (RGEN) have been net sellers, shedding 32,368 shares worth roughly $6.0M on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. RGEN sits in the Health Care Equipment & Supplies industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 92.8K | - | - | |
| Dir | 89.1K | $11.13M | - | |
| CEO | 45.8K | $8.70M | -5,535 | |
| Dir | 40.1K | - | - | |
| COO | 25.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Loeillot Olivier | Chief Executive Officer | Sale+OE10b5-1 | 5,535 | $187.29 | $1,036,653.75 | -10.8% | - | - | |
| Sep 24, 2026 | Loeillot Olivier | Chief Executive Officer | Sale+OE10b5-1 | 12,946 | $190.00 | $2,459,740.00 | -21.1% | - | - | |
| Sep 21, 2026 | Loeillot Olivier | Chief Executive Officer | Sale+OE10b5-1 | 5,426 | $180.00 | $976,680.00 | -10.1% | - | - | |
| Sep 4, 2026 | Loeillot Olivier | Chief Executive Officer | Sell10b5-1 | 3,035 | $165.90 | $503,506.50 | -5.9% | - | - | |
| Aug 20, 2026 | Loeillot Olivier | Chief Executive Officer | Sale+OE10b5-1 | 5,426 | $180.00 | $976,680.00 | -9.1% | - | - | |
| Jul 16, 2026 | Garland Jason K | CFO | Sell10b5-1 | 530 | $150.00 | $79,500.00 | -2.7% | +20.0% | - | |
| Jun 25, 2026 | Garland Jason K | CFO | Sell10b5-1 | 733 | $145.00 | $106,285.00 | -3.6% | +27.1% | - | |
| Apr 21, 2026 | Loeillot Olivier | Chief Executive Officer | Sell10b5-1 | 3,832 | $140.00 | $536,480.00 | -6.6% | +9.6% | - | |
| Dec 17, 2025 | Dawes Karen A63 | Director | Sell | 275 | $161.00 | $44,275.00 | -0.3% | -24.0% | - | |
| Nov 25, 2025 | Loeillot Olivier | Chief Executive Officer | Sell10b5-1 | 7,041 | $170.00 | $1,196,970.00 | -16.4% | -21.0% | - |